Oxygen Biotherapeutics Mission & Goals

News & Events

Recent Scientific Publications Highlight Potential Benefits of Levosimendan in Cardiac Surgery and Additional Critical Care Conditions

 

Publications review potential benefits of levosimendan in various critical care conditions including: cardiac surgery, cardiogenic shock, septic shock, acute renal failure


Wednesday, July 9, 2014 5:30 am PDT
Dateline:
MORRISVILLE, N.C.

Public Company Information:
NASDAQ:OXBT


MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today highlighted three recent review articles examining the current clinical use of levosimendan and its potential to address a wide range of critical care conditions. more..

Quick Links

About Oxygen Biotherapeutics Mission

The Mission of Oxygen Biotherapeutics is to develop and market specialty pharmaceutical products that address unmet needs of critical care patients, their health care providers, and the hospitals who treat these patients.